lanadelumab
SpainDrugs containing this active substance
-
It is used to prevent attacks of hereditary angioedema (HAE) in patients from 2 years of age with a body weight of less than 40 kg.
Form: solution for injection
Active substance Dosage lanadelumab 150 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
It is used in patients from 2 years of age with hereditary angioedema (HAE) to prevent attacks of this disease.
Form: solution for injection
Active substance Dosage lanadelumab 300 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch